BioSpace News Archive

Genetown

Biogen Reps Blacklisted from DC Neurology Centers Due to Aduhelm

The Neurology Center posted a notice, saying, “At this time, the NCPA physicians will not be recommending this treatment for any of its patients.”

September 23, 2021
·
3 min read
·
Mark Terry
Business

AstraZeneca Dives into RNA Research with VaxEquity Collaboration

AstraZeneca aims to harness VaxEquity’s saRNA platform for use with its own therapeutic programs and intends to widely use it on up to 26 different drug targets.

September 23, 2021
·
2 min read
·
Alex Keown
Umbilical Cord Protein Could Increase Stroke Survival and Recovery Rates

Scientists found recently that a naturally occurring protein from human umbilical cord blood might be the key to increasing survival and recovery rates in stroke patients.

September 23, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Evidence Mounting for TILs as Possible First-Line Cancer Therapy

Study: Adoptive cell transfer of tumor-infiltrating lymphocytes (ACT-TILs) is more effective in patients who have not been treated with checkpoint inhibitors than in those who have undergone one or more therapies.

September 23, 2021
·
4 min read
·
Gail Dutton
BioMidwest

Dr. James Lynch of Spine Nevada Becomes First Surgeon to Use Augmedics xvision Spine System with Recently FDA Cleared Perc Pin

Dr. James Lynch of Spine Nevada, a board-certified neurological surgeon with multiple fellowships in the field of spine, recently became the first surgeon to use the Augmedics xvision Spine System with Perc Pin.

September 23, 2021
·
3 min read
ADC Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference

ADC Therapeutics SA announced today that Chris Martin, Chief Executive Officer, will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on Thursday, September 30th at 9:20 a.m. ET.

September 23, 2021
·
2 min read
Biotech Bay

Iovance Biotherapeutics Initiates Clinical Supply of Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy Manufactured at Iovance Cell Therapy Center (iCTC)

Iovance Biotherapeutics, Inc. today reported that the Iovance Cell Therapy Center ( i CTC ) successfully manufactured and delivered the first clinical batch of TIL cell therapy LN-145.

September 23, 2021
·
6 min read
Business

MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration

Mind Medicine and Liechti Lab is pleased to announce that Dr. Matthias Liechti presented data from several ongoing studies at the INSIGHT Conference in Berlin, Germany

September 23, 2021
·
5 min read
Pharm Country

Provention Bio to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference 2021

Provention Bio, Inc. today announced that management will participate in a fireside chat presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference 2021 on Wednesday, September 29, 2021 at 3:20 pm E.T.

September 23, 2021
·
1 min read
Genetown

Stealth BioTherapeutics Presents Positive SBT-272 Preclinical Data at International Parkinson and Movement Disorder Society Virtual Congress 2021

Stealth BioTherapeutics Corp announced today the presentation of new promising data from a study evaluating the effects of SBT-272 in a murine model of Parkinson’s disease (PD).

September 23, 2021
·
6 min read